Cargando…
Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766470/ https://www.ncbi.nlm.nih.gov/pubmed/36485172 http://dx.doi.org/10.1080/21645515.2022.2150454 |
_version_ | 1784853737841360896 |
---|---|
author | Guillaume, Dominique Waheed, Dur-e-Nayab Schlieff, Meike Muralidharan, Kirthini Vorsters, Alex Limaye, Rupali |
author_facet | Guillaume, Dominique Waheed, Dur-e-Nayab Schlieff, Meike Muralidharan, Kirthini Vorsters, Alex Limaye, Rupali |
author_sort | Guillaume, Dominique |
collection | PubMed |
description | Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal. Our study evaluated key factors that drive the decision-making process for the implementation of HPV vaccine programs in LMICs. Stakeholder analysis and semi-structured in-depth interviews were conducted with national and global stakeholders. Interview data were analyzed through qualitative descriptive methods. Findings from our study revealed the decision-making process for HPV vaccines requires the involvement of multiple institutions and stakeholders from national and global levels, with decision-making being a country-specific process. Partner considerations, locally driven processes, availability of data, and infrastructure and resource considerations were found to be critical factors in the decision-making process. Future programs should evaluate the best approaches for investing in initiatives to enhance coordination, ensure vaccine introduction is locally driven, increase the availability of data needed for decision-making, and equip countries with the necessary resources to guide country decision-making in the face of increasingly complex decision-making environments. |
format | Online Article Text |
id | pubmed-9766470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-97664702022-12-21 Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives Guillaume, Dominique Waheed, Dur-e-Nayab Schlieff, Meike Muralidharan, Kirthini Vorsters, Alex Limaye, Rupali Hum Vaccin Immunother HPV – Research Article Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal. Our study evaluated key factors that drive the decision-making process for the implementation of HPV vaccine programs in LMICs. Stakeholder analysis and semi-structured in-depth interviews were conducted with national and global stakeholders. Interview data were analyzed through qualitative descriptive methods. Findings from our study revealed the decision-making process for HPV vaccines requires the involvement of multiple institutions and stakeholders from national and global levels, with decision-making being a country-specific process. Partner considerations, locally driven processes, availability of data, and infrastructure and resource considerations were found to be critical factors in the decision-making process. Future programs should evaluate the best approaches for investing in initiatives to enhance coordination, ensure vaccine introduction is locally driven, increase the availability of data needed for decision-making, and equip countries with the necessary resources to guide country decision-making in the face of increasingly complex decision-making environments. Taylor & Francis 2022-12-09 /pmc/articles/PMC9766470/ /pubmed/36485172 http://dx.doi.org/10.1080/21645515.2022.2150454 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | HPV – Research Article Guillaume, Dominique Waheed, Dur-e-Nayab Schlieff, Meike Muralidharan, Kirthini Vorsters, Alex Limaye, Rupali Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title | Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title_full | Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title_fullStr | Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title_full_unstemmed | Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title_short | Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives |
title_sort | key decision-making factors for human papillomavirus (hpv) vaccine program introduction in low-and-middle-income-countries: global and national stakeholder perspectives |
topic | HPV – Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766470/ https://www.ncbi.nlm.nih.gov/pubmed/36485172 http://dx.doi.org/10.1080/21645515.2022.2150454 |
work_keys_str_mv | AT guillaumedominique keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives AT waheeddurenayab keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives AT schlieffmeike keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives AT muralidharankirthini keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives AT vorstersalex keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives AT limayerupali keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives |